Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 4049-4057

  Liu, Zhanju ^a   Colpaert, Stefaan ^a   D'Haens, Geert R ^a   Kasran, Ahmad ^a   De Boer, Mark ^a,b   Rutgeerts, Paul ^a   Geboes, Karel ^a   Ceuppens, Jan L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Tanox Pharma BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 12; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

ADULT; ANTIGENS, CD40; B-LYMPHOCYTE SUBSETS; CD40 LIGAND; CELLS, CULTURED; COCULTURE TECHNIQUES; COLON; CYTOKINES; FEMALE; HUMANS; ILEUM; IMMUNOPHENOTYPING; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-12; INTESTINAL MUCOSA; KINETICS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033214529     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. MacDermott, R. P. 1994. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med. Clin. North Am. 78:1207.
2. Sartor, R. B. 1997. Pathogenesis and immune mechanisms of chronic inflammatory bowel disease. Am. J. Gastroenterol. 92:5S.
3. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182.
4. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J. Immunol. 157:1261.
5. Murch, S. H., C. P. Braegger, J. A. Walker-Smith, and T. T. MacDonald. 1993. Location of tumor necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 34:1705.
6. Parronchi, P., P. Romagnani, F. Annunziato, S. Sampognaro, A. Becchio, L. Giannarini, E. Maggi, C. Pupilli, F. Tonelli, and S. Romagnani. 1997. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150:823.
7. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3:171.
8. Pospai, D., E. Rene, R. Fiasse, K. Farahat, L. Beaugery, P. Lammens, C. Reimund, B. Duclos, Y. Le Quintrec, B. Vandercam, and M. Mignon. 1998. Crohn's disease stable remission after human immunodeficient virus infection. Dig. Dis. Sci. 43:412.
9. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
10. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
11. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330.
12. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
13. + T-cell responses. Immunol. Today 9:410.
14. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669.
15. Kiener, P. A., P. Moran-Davis, B. M. Rankin, A. F. Wahl, A. Aruffo, and D. Hollenbaugh. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:4917.
16. Shu, U., M. Kiniwa, C. Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125.
17. Kennedy, M. K., K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin, and K. M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370.
18. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
19. Henn, V., J. R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, G. Muller-Berghaus, and R. A. Kroczek. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591.
20. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, W. C. Fanslow, J. Belmont, and M. K. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.
21. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
22. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
23. Stout, R. D., J. Suttles, J. Xu, I. S. Grewal, and R. A. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:8.
24. Grewal, I. S., P. Borrow, E. G. Pamer, M. B. A. Oldstone, and R. A. Flavell. 1997. The CD40-CD154 system in anti-infective host defense. Curr. Opin. Immunol. 9:491.
25. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263.
26. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
27. Desai-Mehta, A., L. Lu, R. Ramsey-Goldman, and S. K. Datta. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:2063.
28. Koshy, M., D. Berger, and M. K. Crow. 1996. Increased expression of CD40 ligand on systemic lupus erythematous lymphocytes. J. Clin. Invest. 98:826.
29. MacDonald, K. P. A., Y. Nishioka, P. E. Lipsky, and R. Thomas. 1997. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J. Clin. Invest. 100:2404.
30. Gerritse, K., J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. A. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:2499.
31. Faure, G. C., D. Bensoussan-Lejzerowicz, M. C. Bene, V. Aubert, and J. Leclere. 1997. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. Clin. Immunol. Immmunopathol. 84:212.
32. Reul, R. M., J. C. Fang, M. D. Denton, C. Geehan, C. Long, R. N. Mitchell, P. Ganz, and D. M. Briscoe. 1997. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 64:1765.
33. Kalled, S. L., A. H. Culler, S. K. Datta, and D. W. Thomas. 1998. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 160:2158.
34. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328.
35. Carayanniotis, G., S. R. Masters, and R. J. Noelle. 1997. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421.
36. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn, T. C. Pearson. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
37. Stüber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693.
38. Clegg, C. H., J. T. Rulffes, H. S. Haugen, I. H. Hoggatt, A. Aruffo, S. K. Durham, A. G. Farr, and D. Hollenbaugh. 1997. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int. Immunol. 9:1111.
39. Kwekkeboom, J., D. de Rijk, A. Kasran, S. Barcy, C. de Groot, and M. de Boer. 1994. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction. Eur. J. Immunol. 24:508.
40. Armant, M., R. Armitage, N. Boiani, G. Delespesse, and M. Sarfati. 1996. Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: involvement in interleukin-2-induced induced interleukin-12 and interferon-γ production. Eur. J. Immunol. 26:1430.
41. Ceuppens, J. L., M. L. Baroja, K. Lorre, J. Van Damme, and A. Billiau. 1988. Human T cell activation with PHA: the function of IL-6 as an accessory signal. J. Immunol. 141:3868.
42. Bull, D. M., and M. A. Bookman. 1977. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J. Clin. Invest. 59:966.
43. Peetermans, W. E., G. R. D'Haens, J. L. Ceuppens, P. Rutgeerts, and K. Geboes. 1995. Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease. Gastroenterology 108:75.
44. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, and R. Dzialo. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183:147.
45. Castle, B. E., K. Kishimoto, C. Stearns, M. L. Brown, and M. R. Kehry. 1993. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151:1777.
46. + cells in IgE production. J. Immunol. 156:1781.
47. Gately, M. K., L. M. Renzett, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune response. Annu. Rev. Immunol. 16:495.
48. Eigler, A., B. Sinha, G. Hartmann, and S. Endres. 1997. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol. Today 10:487.
49. Mencacci, A., E. Cenci, G. Del Sero, C. Fè d'Ostiani, P. Mosci, C. Montagnoli, A. Bacci, F. Bistoni, V. F. J. Quesniaux, B. Ryffel, and L. Romani. 1998. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/ lymphotoxin-α double-deficient mice infected with Candida albicans. Int. Immunol. 10:37.
50. + T cells. Immunity 1:553.
51. Targan, S. R., S. B. Hanauer, S. J. H. van Deventer, L. Mayer, D. H. Present, T. Braakman, K. L. DeWoody, T. F. Schaible, and P. J. Rutgeerts. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N. Engl. J. Med. 337:1029.
52. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stüber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
53. Nishioka, Y., and P. E. Lipsky. 1994. The role of CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol. 153:1027.
54. Burdin, N., L. Galibert, P. Garrone, I. Durand, J. Banchereau, and F. Rousset. 1996. Inability to produce IL-6 is a functional feature of human germinal center B lymphocytes. J. Immunol. 156:4107.
55. Schultze, J. L., S. Michalak, J. Lowne, A. Wong, M. H. Gilleece, J. G. Gribben, and L. M. Nadler. 1999. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J. Exp. Med. 189:1.
56. Rugtveit, J., A. Bakka, and P. Brandtzaeg. 1997. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin. Exp. Immunol. 110:104.
57. Peng, X., A. Kasran, P. A. M. Warmerdam, M. de Boer, and J. L. Ceuppens. 1996. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 type cytokines and synergy with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26:1621.
58. + T cell clones allow B cell growth and differentiation. Eur J. Immunol. 25:2972.